Related Experiment Video
Updated: Aug 5, 2026

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
CD14 and LBP in endotoxemia and infections caused by Gram-negative bacteria
1Division of Infectious Diseases, CHUV, Lausanne, Switzerland. dheumann@hola.hospvd.ch
Abstract:
It is now well recognized that plasma LPS-binding protein (LBP) and membrane CD14 present at the surface of cells of the myelo/monocytic lineage are central molecules of the innate immune system, in response to LPS or to bacterial products. This paper reviews the role of LBP and CD14 in models of endotoxemia and infection.
Insights
Plasma lipopolysaccharide-binding protein (LBP) and CD14 are key innate immune molecules. This review examines their roles in endotoxemia and infection models.
Area of Science:
- Immunology
- Microbiology
Background:
- Plasma lipopolysaccharide-binding protein (LBP) and membrane CD14 are crucial for innate immunity.
- These molecules are involved in the response to lipopolysaccharide (LPS) and other bacterial products.
Purpose of the Study:
- To review the roles of LBP and CD14.
- To explore their functions in models of endotoxemia and infection.
Main Methods:
- Literature review of studies on LBP and CD14.
- Analysis of findings from endotoxemia and infection models.
Main Results:
- LBP and CD14 are central to the innate immune response.
- Their involvement in endotoxemia and infection is significant.
Conclusions:
- LBP and CD14 are critical components of the innate immune system.
- Understanding their roles is vital for studying infectious diseases and sepsis.
Related Concept Videos
Formation of Lipopolysaccharides
Bacterial Toxins
Bacterial Gastroenteritis

